Dror Bacher - Nov 2, 2021 Form 4 Insider Report for DarioHealth Corp. (DRIO)

Role
Chief Operating Officer
Signature
/s/ Dror Bacher
Stock symbol
DRIO
Transactions as of
Nov 2, 2021
Transactions value $
-$236,519
Form type
4
Date filed
11/4/2021, 06:00 PM
Previous filing
Oct 12, 2021
Next filing
Nov 8, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DRIO Common Stock Sale -$83.2K -4.36K -2.36% $19.07* 180K Nov 2, 2021 Direct F1, F2
transaction DRIO Common Stock Sale -$153K -8.02K -4.45% $19.13* 172K Nov 3, 2021 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2021.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.00 to $19.15, inclusive. The Reporting Person undertakes to provide to DarioHealth Corp. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2).
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.00 to $19.38, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3).